Epithelial-to-mesenchymal transition leads to docetaxel resistance in prostate cancer and is mediated by reduced expression of miR-200c and miR-205

American Journal of Pathology

Volumn 181, Issue 6, 2012, Pages 2188-2201

  Puhr, Martin ^a   Hoefer, Julia ^a   Schäfer, Georg ^a   Erb, Holger H H ^a   Oh, Su Jung ^a   Klocker, Helmut ^a   Heidegger, Isabel ^a   Neuwirt, Hannes ^a   Culig, Zoran ^a  

^a INNSBRUCK MEDICAL UNIVERSITY   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; DOCETAXEL; MICRORNA; MICRORNA 200C; MICRORNA 205; UVOMORULIN;

ADJUVANT CHEMOTHERAPY; ARTICLE; CANCER CELL; CANCER RECURRENCE; CANCER RESISTANCE; CANCER STEM CELL; CELL INVASION; CELL MIGRATION; CELL SELECTION; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; DISEASE SEVERITY; DRUG MECHANISM; ENZYME ASSAY; EPITHELIAL MESENCHYMAL TRANSITION; EPITHELIUM CELL; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; IN VIVO STUDY; MALE; MEDIATOR; MESENCHYME CELL; PHENOTYPE; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATECTOMY; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; RECEPTOR UPREGULATION; REGULATOR GENE; SCREENING TEST; TISSUE MICROARRAY;

APOPTOSIS; CADHERINS; CELL LINE, TUMOR; CELL PROLIFERATION; CHEMOTHERAPY, ADJUVANT; DOWN-REGULATION; DRUG RESISTANCE, NEOPLASM; EPITHELIAL-MESENCHYMAL TRANSITION; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MALE; MICRORNAS; NEOPLASM INVASIVENESS; NEOPLASTIC STEM CELLS; PROSTATIC NEOPLASMS; SPHEROIDS, CELLULAR; TAXOIDS; TUMOR MARKERS, BIOLOGICAL; TUMOR STEM CELL ASSAY; UP-REGULATION;

EID: 84869160169     PISSN: 00029440     EISSN: 15252191     Source Type: Journal    
DOI: 10.1016/j.ajpath.2012.08.011     Document Type: Article

References (55)

1. S.G. Patterson, S. Wei, X. Chen, D.A. Sallman, D.L. Gilvary, B. Zhong, J. Pow-Sang, T. Yeatman, J.Y. Djeu Novel role of Stat1 in the development of docetaxel resistance in prostate tumor cells Oncogene 25 2006 6113 6122
2. Y. Xie, K. Xu, D.E. Linn, X. Yang, Z. Guo, H. Shimelis, T. Nakanishi, D.D. Ross, H. Chen, L. Fazli, M.E. Gleave, Y. Qiu The 44-kDa Pim-1 kinase phosphorylates BCRP/ABCG2 and thereby promotes its multimerization and drug-resistant activity in human prostate cancer cells J Biol Chem 283 2008 3349 3356
3. G. Ploussard, S. Terry, P. Maille, Y. Allory, N. Sirab, L. Kheuang, P. Soyeux, N. Nicolaiew, E. Coppolani, B. Paule, L. Salomon, S. Culine, R. Buttyan, F. Vacherot, A. de la Taille Class III beta-tubulin expression predicts prostate tumor aggressiveness and patient response to docetaxel-based chemotherapy Cancer Res 70 2010 9253 9264
4. R. de Wit Chemotherapy in hormone-refractory prostate cancer BJU Int 101 Suppl 2 2008 11 15
5. I.F. Tannock, R. de Wit, W.R. Berry, J. Horti, A. Pluzanska, K.N. Chi, S. Oudard, C. Theodore, N.D. James, I. Turesson, M.A. Rosenthal, M.A. Eisenberger Docetaxel plus prednisone or mitoxantrone plus prednisone for advanced prostate cancer N Engl J Med 351 2004 1502 1512
6. A.J. Armstrong, E. Garrett-Mayer, R. de Wit, I. Tannock, M. Eisenberger Prediction of survival following first-line chemotherapy in men with castration-resistant metastatic prostate cancer Clin Cancer Res 16 2010 203 211
7. M.A. Kim, H.S. Lee, H.E. Lee, J.H. Kim, H.K. Yang, W.H. Kim Prognostic importance of epithelial-mesenchymal transition-related protein expression in gastric carcinoma Histopathology 54 2009 442 451
8. A. Soltermann, V. Tischler, S. Arbogast, J. Braun, N. Probst-Hensch, W. Weder, H. Moch, G. Kristiansen Prognostic significance of epithelial-mesenchymal and mesenchymal-epithelial transition protein expression in non-small cell lung cancer Clin Cancer Res 14 2008 7430 7437
9. O. Schmalhofer, S. Brabletz, T. Brabletz E-cadherin, beta-catenin, and ZEB1 in malignant progression of cancer Cancer Metastasis Rev 28 2009 151 166
10. J. Yang, S.A. Mani, J.L. Donaher, S. Ramaswamy, R.A. Itzykson, C. Come, P. Savagner, I. Gitelman, A. Richardson, R.A. Weinberg Twist, a master regulator of morphogenesis, plays an essential role in tumor metastasis Cell 117 2004 927 939
11. E. Batlle, E. Sancho, C. Franci, D. Dominguez, M. Monfar, J. Baulida, A. Garcia De Herreros The transcription factor snail is a repressor of E-cadherin gene expression in epithelial tumour cells Nat Cell Biol 2 2000 84 89
12. A. Singh, J. Settleman EMT, cancer stem cells and drug resistance: an emerging axis of evil in the war on cancer Oncogene 29 2010 4741 4751
13. G. Agiostratidou, J. Hulit, G.R. Phillips, R.B. Hazan Differential cadherin expression: potential markers for epithelial to mesenchymal transformation during tumor progression J Mammary Gland Biol Neoplasia 12 2007 127 133
14. S.M. Park, A.B. Gaur, E. Lengyel, M.E. Peter The miR-200 family determines the epithelial phenotype of cancer cells by targeting the E-cadherin repressors ZEB1 and ZEB2 Genes Dev 22 2008 894 907
15. P.A. Gregory, A.G. Bert, E.L. Paterson, S.C. Barry, A. Tsykin, G. Farshid, M.A. Vadas, Y. Khew-Goodall, G.J. Goodall The miR-200 family and miR-205 regulate epithelial to mesenchymal transition by targeting ZEB1 and SIP1 Nat Cell Biol 10 2008 593 601
16. G. Childs, M. Fazzari, G. Kung, N. Kawachi, M. Brandwein-Gensler, M. McLemore, Q. Chen, R.D. Burk, R.V. Smith, M.B. Prystowsky, T.J. Belbin, N.F. Schlecht Low-level expression of microRNAs let-7d and miR-205 are prognostic markers of head and neck squamous cell carcinoma Am J Pathol 174 2009 736 745
17. M.J. Schliekelman, D.L. Gibbons, V.M. Faca, C.J. Creighton, Z.H. Rizvi, Q. Zhang, C.H. Wong, H. Wang, C. Ungewiss, Y.H. Ahn, D.H. Shin, J.M. Kurie, S.M. Hanash Targets of the tumor suppressor miR-200 in regulation of the epithelial-mesenchymal transition in cancer Cancer Res 71 2011 7670 7682
18. S.A. Mani, W. Guo, M.J. Liao, E.N. Eaton, A. Ayyanan, A.Y. Zhou, M. Brooks, F. Reinhard, C.C. Zhang, M. Shipitsin, L.L. Campbell, K. Polyak, C. Brisken, J. Yang, R.A. Weinberg The epithelial-mesenchymal transition generates cells with properties of stem cells Cell 133 2008 704 715
19. M. Puhr, F.R. Santer, H. Neuwirt, M. Susani, J.A. Nemeth, A. Hobisch, L. Kenner, Z. Culig Down-regulation of suppressor of cytokine signaling-3 causes prostate cancer cell death through activation of the extrinsic and intrinsic apoptosis pathways Cancer Res 69 2009 7375 7384
20. J. Hoefer, G. Schafer, H. Klocker, H.H. Erb, I.G. Mills, L. Hengst, M. Puhr, Z. Culig PIAS1 is increased in human prostate cancer and enhances proliferation through inhibition of p21 Am J Pathol 180 2012 2087 2107
21. S. Detre, G. Saclani Jotti, M. Dowsett A "quickscore" method for immunohistochemical semiquantitation: validation for oestrogen receptor in breast carcinomas J Clin Pathol 48 1995 876 878
22. B. Zhong, D.A. Sallman, D.L. Gilvary, D. Pernazza, E. Sahakian, D. Fritz, J.Q. Cheng, I. Trougakos, S. Wei, J.Y. Djeu Induction of clusterin by AKT: role in cytoprotection against docetaxel in prostate tumor cells Mol Cancer Ther 9 2010 1831 1841
23. R.D. Sowery, B.A. Hadaschik, A.I. So, A. Zoubeidi, L. Fazli, A. Hurtado-Coll, M.E. Gleave Clusterin knockdown using the antisense oligonucleotide OGX-011 re-sensitizes docetaxel-refractory prostate cancer PC-3 cells to chemotherapy BJU Int 102 2008 389 397
24. A.K. Perl, P. Wilgenbus, U. Dahl, H. Semb, G. Christofori A causal role for E-cadherin in the transition from adenoma to carcinoma Nature 392 1998 190 193
25. M. Muramaki, H. Miyake, T. Terakawa, Y. Kusuda, M. Fujisawa Expression profile of E-cadherin and N-cadherin in urothelial carcinoma of the upper urinary tract is associated with disease recurrence in patients undergoing nephroureterectomy Urology 78 2011 1443.e7 1443.e12
26. P.C. Black, G.A. Brown, T. Inamoto, M. Shrader, A. Arora, A.O. Siefker-Radtke, L. Adam, D. Theodorescu, X. Wu, M.F. Munsell, M. Bar-Eli, D.J. McConkey, C.P. Dinney Sensitivity to epidermal growth factor receptor inhibitor requires E-cadherin expression in urothelial carcinoma cells Clin Cancer Res 14 2008 1478 1486
27. S.E. Witta, R.M. Gemmill, F.R. Hirsch, C.D. Coldren, K. Hedman, L. Ravdel, B. Helfrich, R. Dziadziuszko, D.C. Chan, M. Sugita, Z. Chan, A. Baron, W. Franklin, H.A. Drabkin, L. Girard, A.F. Gazdar, J.D. Minna, P.A. Bunn Jr Restoring E-cadherin expression increases sensitivity to epidermal growth factor receptor inhibitors in lung cancer cell lines Cancer Res 66 2006 944 950
28. A. Latifi, K. Abubaker, N. Castrechini, A.C. Ward, C. Liongue, F. Dobill, J. Kumar, E.W. Thompson, M.A. Quinn, J.K. Findlay, N. Ahmed Cisplatin treatment of primary and metastatic epithelial ovarian carcinomas generates residual cells with mesenchymal stem cell-like profile J Cell Biochem 112 2011 2850 2864
29. A.E. Sayan, T.R. Griffiths, R. Pal, G.J. Browne, A. Ruddick, T. Yagci, R. Edwards, N.J. Mayer, H. Qazi, S. Goyal, S. Fernandez, K. Straatman, G.D. Jones, K.J. Bowman, A. Colquhoun, J.K. Mellon, M. Kriajevska, E. Tulchinsky SIP1 protein protects cells from DNA damage-induced apoptosis and has independent prognostic value in bladder cancer Proc Natl Acad Sci U S A 106 2009 14884 14889
30. S. Bindels, M. Mestdagt, C. Vandewalle, N. Jacobs, L. Volders, A. Noël, F. van Roy, G. Berx, J.M. Foidart, C. Gilles Regulation of vimentin by SIP1 in human epithelial breast tumor cells Oncogene 25 2006 4975 4985
31. N. Bhatnagar, X. Li, S.K. Padi, Q. Zhang, M.S. Tang, B. Guo Downregulation of miR-205 and miR-31 confers resistance to chemotherapy-induced apoptosis in prostate cancer cells Cell Death Dis 1 2010 e105
32. M.V. Iorio, P. Casalini, C. Piovan, G. Di Leva, A. Merlo, T. Triulzi, S. Menard, C.M. Croce, E. Tagliabue microRNA-205 regulates HER3 in human breast cancer Cancer Res 69 2009 2195 2200
33. H. Wu, S. Zhu, Y.Y. Mo Suppression of cell growth and invasion by miR-205 in breast cancer Cell Res 19 2009 439 448
34. Y. Xu, T. Brenn, E.R. Brown, V. Doherty, D.W. Melton Differential expression of microRNAs during melanoma progression: miR-200c, miR-205 and miR-211 are downregulated in melanoma and act as tumour suppressors Br J Cancer 106 2012 553 561
35. P. Gandellini, M. Folini, N. Longoni, M. Pennati, M. Binda, M. Colecchia, R. Salvioni, R. Supino, R. Moretti, P. Limonta, R. Valdagni, M.G. Daidone, N. Zaffaroni miR-205 exerts tumor-suppressive functions in human prostate through down-regulation of protein kinase Cepsilon Cancer Res 69 2009 2287 2295
36. H. Song, G. Bu MicroRNA-205 inhibits tumor cell migration through down-regulating the expression of the LDL receptor-related protein 1 Biochem Biophys Res Commun 388 2009 400 405
37. S. Jurmeister, M. Baumann, A. Balwierz, I. Keklikoglou, A. Ward, S. Uhlmann, J.D. Zhang, S. Wiemann, O. Sahin MicroRNA-200c represses migration and invasion of breast cancer cells by targeting actin-regulatory proteins FHOD1 and PPM1F Mol Cell Biol 32 2012 633 651
38. M. Zemskova, E. Sahakian, S. Bashkirova, M. Lilly The PIM1 kinase is a critical component of a survival pathway activated by docetaxel and promotes survival of docetaxel-treated prostate cancer cells J Biol Chem 283 2008 20635 20644
39. D. Nalls, S.N. Tang, M. Rodova, R.K. Srivastava, S. Shankar Targeting epigenetic regulation of miR-34a for treatment of pancreatic cancer by inhibition of pancreatic stem cells PLoS One 6 2011 e24099
40. D. Kong, S. Banerjee, A. Ahmad, Y. Li, Z. Wang, S. Sethi, F.H. Sarkar Epithelial to mesenchymal transition is mechanistically linked with stem cell signatures in prostate cancer cells PLoS One 5 2010 e12445
41. S. Kasper Identification, characterization, and biological relevance of prostate cancer stem cells from clinical specimens Urol Oncol 27 2009 301 303
42. G.D. Richardson, C.N. Robson, S.H. Lang, D.E. Neal, N.J. Maitland, A.T. Collins CD133, a novel marker for human prostatic epithelial stem cells J Cell Sci 117 2004 3539 3545
43. N. Saeki, J. Gu, T. Yoshida, X. Wu Prostate stem cell antigen: a Jekyll and Hyde molecule Clin Cancer Res 16 2010 3533 3538
44. A.T. Collins, P.A. Berry, C. Hyde, M.J. Stower, N.J. Maitland Prospective identification of tumorigenic prostate cancer stem cells Cancer Res 65 2005 10946 10951
45. L. Patrawala, T. Calhoun, R. Schneider-Broussard, H. Li, B. Bhatia, S. Tang, J.G. Reilly, D. Chandra, J. Zhou, K. Claypool, L. Coghlan, D.G. Tang Highly purified CD44+ prostate cancer cells from xenograft human tumors are enriched in tumorigenic and metastatic progenitor cells Oncogene 25 2006 1696 1708
46. X. Li, M.T. Lewis, J. Huang, C. Gutierrez, C.K. Osborne, M.F. Wu, S.G. Hilsenbeck, A. Pavlick, X. Zhang, G.C. Chamness, H. Wong, J. Rosen, J.C. Chang Intrinsic resistance of tumorigenic breast cancer cells to chemotherapy J Natl Cancer Inst 100 2008 672 679
47. C. Yang, M. Zeisberg, J.C. Lively, P. Nyberg, N. Afdhal, R. Kalluri Integrin alpha1beta1 and alpha2beta1 are the key regulators of hepatocarcinoma cell invasion across the fibrotic matrix microenvironment Cancer Res 63 2003 8312 8317
48. D.J. Vander Griend, W.L. Karthaus, S. Dalrymple, A. Meeker, A.M. DeMarzo, J.T. Isaacs The role of CD133 in normal human prostate stem cells and malignant cancer-initiating cells Cancer Res 68 2008 9703 9711
49. M.L. Zhu, N. Kyprianou Role of androgens and the androgen receptor in epithelial-mesenchymal transition and invasion of prostate cancer cells FASEB J 24 2010 769 777
50. Y. Sun, B.E. Wang, K.G. Leong, P. Yue, L. Li, S. Jhunjhunwala, D. Chen, K. Seo, Z. Modrusan, W.Q. Gao, J. Settleman, L. Johnson Androgen deprivation causes epithelial-mesenchymal transition in the prostate: implications for androgen-deprivation therapy Cancer Res 72 2012 527 536
51. A.M. Calcagno, C.D. Salcido, J.P. Gillet, C.P. Wu, J.M. Fostel, M.D. Mumau, M.M. Gottesman, L. Varticovski, S.V. Ambudkar Prolonged drug selection of breast cancer cells and enrichment of cancer stem cell characteristics J Natl Cancer Inst 102 2010 1637 1652
52. A. Dubrovska, J. Elliott, R.J. Salamone, S. Kim, L.J. Aimone, J.R. Walker, J. Watson, M. Sauveur-Michel, C. Garcia-Echeverria, C.Y. Cho, V.A. Reddy, P.G. Schultz Combination therapy targeting both tumor-initiating and differentiated cell populations in prostate carcinoma Clin Cancer Res 16 2010 5692 5702
53. K.A. Iczkowski Cell adhesion molecule CD44: its functional roles in prostate cancer Am J Transl Res 3 2011 1 7
54. M. Heatley, P. Maxwell, C. Whiteside, P. Toner Vimentin and cytokeratin expression in nodular hyperplasia and carcinoma of the prostate J Clin Pathol 48 1995 1031 1034
55. S.H. Lang, C. Hyde, I.N. Reid, I.S. Hitchock, C.A. Hart, A.A. Bryden, J.M. Villette, M.J. Stower, N.J. Maitland Enhanced expression of vimentin in motile prostate cell lines and in poorly differentiated and metastatic prostate carcinoma Prostate 52 2002 253 263